In both the E.G7-OVA lymphoma model and the Lewis lung carcinoma model, vaccination using an amino-rich FN nanoplatform loaded with tumor antigens and immunostimulatory CpG ODNs greatly enhances the cell populations of typical T lymphocytes in splenocytes such as CD4+ and CD8+ T cells. The gene discussed is CD8A; the disease is neoplasm.